Brimonidine
Authors:
- 1 August 1997
- journal article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 6 (8) , 1063-1083
Abstract
Brimonidine tartrate is a highly selective 2-adrenergic receptor agonist indicated for the chronic treatment of glaucoma and ocular hypertension. Glaucoma, a serious worldwide public health problem causing blindness in 5.2 million people, is treated by drugs that lower the intraocular pressure (IOP), a primary risk factor in glaucomatous optic neuropathy. Currently, beta-blockers are the most common therapy. In two 12-month clinical comparison trials with timolol 0.5% (n = 926), twice-daily brimonidine produced IOP lowering comparable to twice-daily timolol. In a 3-month trial with betaxolol 0.25% suspension (n = 206), twice-daily brimonidine was more effective in lowering IOP than twice-daily betaxolol. Brimonidine was well-tolerated ocularly and systemically in these trials. It caused no clinically significant mean changes in heart rate or blood pressure. Brimonidine produced no significant effect on FEV1 in clinical trials, and it is not contraindicated in patients with cardiopulmonary disease. Brimoni...Keywords
This publication has 32 references indexed in Scilit:
- Number of people with glaucoma worldwide.British Journal of Ophthalmology, 1996
- Comparison Oftheocular Beta-BlockersAnnals of Pharmacotherapy, 1996
- A Double-Masked, Randomized 1-Year Study Comparing Dorzolamide (Trusopt), Timolol, and BetaxololArchives of Ophthalmology (1950), 1995
- Topical Ophthalmic β‐Adrenergic Blockade for the Treatment of Glaucoma and Ocular HypertensionThe Journal of Clinical Pharmacology, 1994
- Ocular ??-Blockers in Glaucoma ManagementDrugs & Aging, 1992
- Long-Term Betaxolol Therapy in Glaucoma Patients With Pulmonary DiseaseAmerican Journal of Ophthalmology, 1988
- Respiratory Difficulties With BetaxololAmerican Journal of Ophthalmology, 1986
- Long-term Drift and Continued Efficacy After Multiyear Timolol TherapyArchives of Ophthalmology (1950), 1981
- Adverse Reactions from Timolol AdministrationOphthalmology, 1980
- Longterm timolol therapySurvey of Ophthalmology, 1979